WASHINGTON, June 15 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for License: Fluorophthalimides as Anti-Inflammatory Agents for Systemic and Neurodegenerative Disorders.
The notice was published in the Federal Register on June 15 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.
Summary: The National Institute on Aging (NIA) seeks research co-development partners and/or licensees for the pre-clinical and clinical development of the compounds as anti-inflammatory therapeutics for systemic and neurodegenerative disorders.
For more information, contact Inquiries related to this license opportunity should be directed to: Nikki Guyton, Ph....